Omeros Corporation
OMER
#6386
Rank
S$1.01 B
Marketcap
S$14.38
Share price
-5.65%
Change (1 day)
24.07%
Change (1 year)

Earnings for Omeros Corporation (OMER)

Earnings in 2025 (TTM): -S$0.16 Billion

According to Omeros Corporation's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -S$0.21 Billion a decrease over its 2023 earnings that were of -S$0.19 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Omeros Corporation from 2009 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$0.16 Billion-21.08%
2024 -S$0.21 Billion9.63%
2023 -S$0.19 Billion-9.57%
2022 -S$0.21 Billion-30.65%
2021 -S$0.3 Billion86.28%
2020 -S$0.16 Billion99.45%
2019 -S$78.29 Million-49.91%
2018 -S$0.16 Billion190.77%
2017 -S$53.76 Million-27.96%
2016 -S$74.62 Million-17.61%
2015 -S$90.57 Million1.88%
2014 -S$88.9 Million87.56%
2013 -S$47.4 Million
2011 -S$34.71 Million-8.96%
2010 -S$38.13 Million45.03%
2009 -S$26.29 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$41.01 B-27,200.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$15.00 B-10,014.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Genetic Technologies
GENE
-S$4.9 Million-96.77%๐Ÿ‡ฆ๐Ÿ‡บ Australia
Eterna Therapeutics
ERNA
-S$12.02 Million-92.06%๐Ÿ‡บ๐Ÿ‡ธ USA